首页
> 会议日程详情
2025-11-23
08:50-08:58
5楼中华C
Atezolizumab-Bevacizumab Versus Sintilimab-Bevacizumab Biosimilar Combined With Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Real-World Comparative and Cost-Effectiveness Analysis
09:20-09:28
5楼中华C
Transarterial Chemoembolization Combined with Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma and Child-Pugh B7